File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Book Chapter: Prognostic Indicators in MDS and CMML

TitlePrognostic Indicators in MDS and CMML
Authors
Issue Date28-Sep-2023
PublisherSpringer Nature Singapore
Abstract

Various prognostic scoring systems have been developed over the last 2 decades aiming to better risk stratify myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML). Molecular alterations are increasingly important in the current era of personalized medicine. In this chapter, we review the evolution of prognostic models in MDS and CMML and the development of personalized prognostic assessment in these disorders.


Persistent Identifierhttp://hdl.handle.net/10722/341850
ISBN

 

DC FieldValueLanguage
dc.contributor.authorGill, Harinder-
dc.contributor.authorYung, Yammy-
dc.contributor.authorChu, Cherry-
dc.contributor.authorYip, Amber-
dc.date.accessioned2024-03-26T05:37:40Z-
dc.date.available2024-03-26T05:37:40Z-
dc.date.issued2023-09-28-
dc.identifier.isbn9789819938094-
dc.identifier.urihttp://hdl.handle.net/10722/341850-
dc.description.abstract<p>Various prognostic scoring systems have been developed over the last 2 decades aiming to better risk stratify myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML). Molecular alterations are increasingly important in the current era of personalized medicine. In this chapter, we review the evolution of prognostic models in MDS and CMML and the development of personalized prognostic assessment in these disorders.<br></p>-
dc.languageeng-
dc.publisherSpringer Nature Singapore-
dc.relation.ispartofPathogenesis and Treatment of Leukemia-
dc.titlePrognostic Indicators in MDS and CMML-
dc.typeBook_Chapter-
dc.identifier.doi10.1007/978-981-99-3810-0_30-
dc.identifier.eisbn9789819938100-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats